Skip to main content
OpenTrials

Clinical trial condition

Breast Diseases

Explore clinical trials studying Breast Diseases. Study availability and eligibility vary by location and protocol.

10,339 public trials 1,980 recruiting studies
Refine in advanced search Browse all conditions

Breast Diseases trial results

Active, Not Recruiting

PHESGO Maintenance After T-DXd Short Induction for HER2+ Unresectable Locally Recurrent or Metastatic Breast Cancer

NCT06172127

Conditions
Breast Diseases, Breast Neoplasms, HER2-positive Breast Cancer, +4 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Northwell Health New York, United States
  • Institute Paoli Calmettes Marseille, France
  • Hopital Europeen Georges Pompidou Paris, France
View all 36 locations
View Trial Details
Active, Not Recruiting

Chemotherapy-Free pCR-Guided Strategy With Trastuzumab-pertuzumab and T-DM1 in HER2-positive Early Breast Cancer

NCT04733118

Conditions
Breast Diseases, Breast Neoplasms, Early Breast Cancer, +4 more
Locations
  • UMHAT Sveti Ivan Rilski EAD Department of Medical Oncology Sofia, Bulgaria
  • Praxisnetzwerk Hämatologie und intern. Onkologie Cologne, Germany
  • Evangelisches Krankenhaus Bethesda Duisburg, Germany
  • Kliniken Essen Mitte Essen, Germany
View all 41 locations
View Trial Details
Active, Not Recruiting

Together After Cancer

NCT05645471

Conditions
Behavior, Breast Cancer, Breast Diseases, +7 more
Locations
  • Sylvester Comprehensive Cancer Center and University of Miami Miami, Florida, United States
  • AdventHealth Orlando, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View Trial Details
Active, Not Recruiting

Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC

NCT05645380

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
Locations
  • The University of Kansas Cancer Center - Clinical Research Center Fairway, Kansas, United States
  • The University of Kansas Cancer Center - Main Hospital Kansas City, Kansas, United States
  • The University of Kansas Cancer Center - Westwood Kansas City, Kansas, United States
  • The University of Kansas Cancer Center - Overland Park Overland Park, Kansas, United States
View Trial Details
Active, Not Recruiting

Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer

NCT01905046

Conditions
Adenocarcinoma, Atypical Ductal Breast Hyperplasia, BRCA1 Mutation Carrier, +16 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Los Angeles County-USC Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • City of Hope South Pasadena South Pasadena, California, United States
View all 27 locations
View Trial Details

Related conditions